Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Announcing CHI’s Clinical Auditing Forum, June 2-3, 2015, Boston, MAQuality Management Systems and Risk Mitigation Strategies for Internal Systems and External Partners
Agenda at-a-Glance: Tuesday, June 2 Implementing Risk-Based Auditing Dirk Gille, Vice President, Head Bioresearch QA, Janssen R&D, Belgium Risk Management: An ICH Perspective Bob Figarotta, Senior Manager, Clinical, Allergan Rethinking CAPA Metrics and TMF Metrics: Are You Measuring the Right Things? Linda B. Sullivan, Co-Founder & President, Metrics Champion Consortium (MCC) Case Study: Building an Effective CAPA Management Process Federico Feldstein, J.D., Vice President, Medical Regulatory Compliance, Pfizer, Inc. Risk-Based Monitoring and Quality Management Systems Denise M. Shelley, MS, Clinical Project Manager II, Clinical Research Directorate, Clinical Monitoring Research Program (CMRP), Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research Dinner Short Course: Quality by Design in Clinical Research: Is This Only for the Protocol? Wednesday, June 3 Avoiding the Leap from 483 to Warning Letter Robert Romanchuk, BSHS, CCRC, CIP, CHRC, Vice Chair, Schulman Associates, IRB Sponsor Oversight: The Importance of Auditing in Vendor Management Beverly Brown, Manager, Global Regulatory Quality, Allergan Decrease Audit Traffic and Increase Audit Value through Broader Audit Scope and Exchange of Information Dr. Barbara Heumann, Managing Director, GXP-Engaged Auditing Services GmbH Debra Ploss, Quality Manager, GXP-Engaged Auditing Services GmbH Risk-Based Audit Planning: Developing a Three Year Strategy Rita Farrell, Compliance Specialist, Global Quality & Regulatory Compliance – Clinical Trials & Safety (GQRC-CT& Randomized Controlled Trials: Ethics, Consenting, Maintaining the Blind, and Protocol Adherence Jerri B. Perkins, M.D., former Medical Officer, FDA Managing Global Inspections Janis A. Little, MS, Vice President, Global Regulatory Quality, Allergan Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com. For details on sponsorship, exhibit and lead generation packages, contact Ilana Quigley, Tel: 781-972-5457, iquigley@healthtech.com. For more information, visit http://www.ClinicalTrialSummit.com/ About Clinical Trial Oversight Summit Cambridge Healthtech Institute's fourth annual Clinical Trial Oversight Summit will feature four co-located conferences covering best practices and recent trends relevant to clinical research monitoring, auditing, clinical quality assurance, site management, and vendor oversight. This three-day summit will brings together 250+ highly targeted decision makers and include presentations, case studies, interactive breakout discussion groups, dinner short courses, and networking opportunities. Themes throughout will include risk-based approaches to clinical trial management, implementing quality systems-based approaches to GCP compliance, ensuring reliable study data, responding to the evolving regulatory landscape, and preparing sites and clinical research partners for inspection-readiness. About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, The Knowledge Foundation, and OpenHelix. http://www.chicorporate.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|